Cargando…

Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments

Detalles Bibliográficos
Autores principales:	Peng, Ge, Okumura, Ko, Ogawa, Hideoki, Ikeda, Shigaku, Niyonsaba, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800418/ https://www.ncbi.nlm.nih.gov/pubmed/35104583 http://dx.doi.org/10.1016/j.jaad.2022.01.041

Ejemplares similares

A Pancancer Analysis of the Oncogenic Role of S100 Calcium Binding Protein A7 (S100A7) in Human Tumors
por: Peng, Ge, et al.
Publicado: (2022)

Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2′-5′ oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection
por: Tsutsui-Takeuchi, Mizuho, et al.
Publicado: (2014)

Experimental and Clinical Evidence Suggests That Treatment with Betacellulin Can Alleviate Th2-Type Cytokine-Mediated Impairment of Skin Barrier Function
por: Peng, Ge, et al.
Publicado: (2022)

The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor
por: Nguyen, Hai Le Thanh, et al.
Publicado: (2023)

The Antimicrobial Peptide Human β-Defensin-3 Accelerates Wound Healing by Promoting Angiogenesis, Cell Migration, and Proliferation Through the FGFR/JAK2/STAT3 Signaling Pathway
por: Takahashi, Miho, et al.
Publicado: (2021)

Topical Gynura procumbens as a Novel Therapeutic Improves Wound Healing in Diabetic Mice
por: Sutthammikorn, Nutda, et al.
Publicado: (2021)

Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis
por: Nguyen, Hai Le Thanh, et al.
Publicado: (2020)

Skin Treatment with Detergent Induces Dermatitis with H1-Antihistamine-Refractory Itch and Upregulates IL-4 and Th17/Th22 Cytokine Gene Expression in C57BL/6 Mice
por: Masutani, Yurie, et al.
Publicado: (2022)

Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
por: Umehara, Yoshie, et al.
Publicado: (2023)

Human β-defensin-3 attenuates atopic dermatitis–like inflammation through autophagy activation and the aryl hydrocarbon receptor signaling pathway
por: Peng, Ge, et al.
Publicado: (2022)

Heparanase Contributes to Psoriatic Lesions Through Crosstalk with IL-17 Pathway
por: Zhu, Chengyao, et al.
Publicado: (2023)

The Antimicrobial Peptides Human β-Defensins Induce the Secretion of Angiogenin in Human Dermal Fibroblasts
por: Umehara, Yoshie, et al.
Publicado: (2022)

IL-17A production in human psoriatic blood and lesions by CD146+ T Cells
por: Mehta, Nehal N., et al.
Publicado: (2014)

Dual inhibition of IL-17A and IL-17F in psoriatic disease
por: Iznardo, Helena, et al.
Publicado: (2021)

Ameliorating effect of Yokukansan on the development of atopic dermatitis-like lesions and scratching behavior in socially isolated NC/Nga mice
por: Funakushi, Naoko, et al.
Publicado: (2011)

Intractable Itch in Atopic Dermatitis: Causes and Treatments
por: Umehara, Yoshie, et al.
Publicado: (2021)

Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies
por: Sánchez-Rodríguez, Guillermo, et al.
Publicado: (2023)

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
por: Alhenc-Gelas, Francois, et al.
Publicado: (2020)

Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritis
por: Cardner, Mathias, et al.
Publicado: (2023)

IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
por: Noordenbos, Troy, et al.
Publicado: (2011)

The IL-17/IL-23 Axis and Its Genetic Contribution to Psoriatic Arthritis
por: Vecellio, Matteo, et al.
Publicado: (2021)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells
por: Yashiro, Takuya, et al.
Publicado: (2015)

Yokukansan, a Traditional Japanese Medicine, Adjusts Glutamate Signaling in Cultured Keratinocytes
por: Wakabayashi, Maki, et al.
Publicado: (2014)

Characteristics of Patients with Generalized Pustular Psoriasis and Psoriatic Arthritis: A Retrospective Cohort Study
por: MANONE-ZENKE, Yukari, et al.
Publicado: (2022)

Niosomal Curcumin Suppresses IL17/IL23 Immunopathogenic Axis in Skin Lesions of Psoriatic Patients: A Pilot Randomized Controlled Trial
por: Kolahdooz, Hanieh, et al.
Publicado: (2023)

The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis
por: Maeda, Shinji, et al.
Publicado: (2012)

Mannan-induced Nos2 in macrophages enhances IL-17–driven psoriatic arthritis by innate lymphocytes
por: Zhong, Jianghong, et al.
Publicado: (2018)

SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor
por: Foti, Rosario, et al.
Publicado: (2020)

Robust induction of neural crest cells to derive peripheral sensory neurons from human induced pluripotent stem cells
por: Umehara, Yoshie, et al.
Publicado: (2020)

Psoriatic Skin Lesions after Apalutamide Treatment
por: MIYAGAWA, Fumi, et al.
Publicado: (2022)

CXCL4 is a novel inducer of human Th17 cells and correlates with IL‐17 and IL‐22 in psoriatic arthritis
por: Affandi, Alsya J., et al.
Publicado: (2018)

The Clinical Significance of Simultaneous IL-17A and IL-17F Blockade in Psoriasis Non-Responding to Anti-IL17A Therapy
por: Kokolakis, Georgios, et al.
Publicado: (2022)

Resolution of synovitis and arrest of catabolic and anabolic bone changes in patients with psoriatic arthritis by IL-17A blockade with secukinumab: results from the prospective PSARTROS study
por: Kampylafka, Eleni, et al.
Publicado: (2018)

The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis
por: Liu, Ningyuan, et al.
Publicado: (2021)

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
por: Sakkas, Lazaros I., et al.
Publicado: (2019)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

Itching sensation in psoriatic patients and its relation to body mass index and IL-17 and IL-31 concentrations
por: Czarnecka-Operacz, Magdalena, et al.
Publicado: (2015)

Clinical, Serological and Immunological Characteristics in Greek Patients with Psoriatic Arthritis: The Role of IL-17, IL-23, and Sclerostin
por: Venetsanopoulou, Aliki I., et al.
Publicado: (2020)

Choosing the Appropriate Target for the Treatment of Psoriatic Arthritis: TNFα, IL-17, IL-23 or JAK Inhibitors?
por: Gialouri, Chrysoula G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2a4d447i7vhsopk7fh597ukhk4